Alkermes (ALKS) EBITDA Margin Growth (3y) (2013 - 2026)
Alkermes (ALKS) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1,673.00 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -37.00 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -1,442.00 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 11,299.00 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 3,972.00 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 5,310.00 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -15,676.00 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 2,466.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -1,106.00 |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 25,177.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15,676.00 |
| Dec 31, 2025 | 2,119.00 |
| Sep 30, 2025 | 209,368.00 |
| Jun 30, 2025 | 103,450.00 |
| Mar 31, 2025 | 2,200.00 |
| Dec 31, 2024 | 3,363.00 |
| Sep 30, 2024 | 3,543.00 |
| Jun 30, 2024 | 2,220.00 |
| Mar 31, 2024 | 1,953.00 |
| Dec 31, 2023 | 4,610.00 |
| Sep 30, 2023 | 1,319.00 |
| Jun 30, 2023 | 4,983.00 |
| Mar 31, 2023 | 198.00 |
| Dec 31, 2022 | 10,201.00 |
| Sep 30, 2022 | -205,187.00 |
| Jun 30, 2022 | -99,750.00 |
| Mar 31, 2022 | 2,835.00 |
| Dec 31, 2021 | 1,919.00 |
| Sep 30, 2021 | 378.00 |
| Jun 30, 2021 | 216,742.00 |